Silicon Valley Capital Partners’s Celgene Corp CELG Stock Holding History

Silicon Valley Capital Partners’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-8,002	Closed	-$926K	–	32
2016 Q4	$926K	Sell	8,002 -3,604	-31%	-$401K	0.62%	14
2016 Q3	$1.21M	Sell	11,606 -754	-6%	-$81.6K	0.89%	13
2016 Q2	$1.22M	Sell	12,360 -96	-0.8%	-$9.93K	0.94%	12
2016 Q1	$1.25M	Buy	+12,456	New	+$1.28M	1.01%	10

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Silicon Valley Capital Partners's CELG Position: Q1 2017 in Review

Silicon Valley Capital Partners sold out of Celgene Corp (CELG) in Q1 2017, closing a stake of 8,002 shares — an estimated $926K sold.

Silicon Valley Capital Partners first reported a position in CELG in Q1 2016 and held it in 4 quarters. The position peaked at $1.25M in Q1 2016. 1,417 funds tracked by Wall St. Rank hold CELG as of Q1 2017.

Silicon Valley Capital Partners reported no remaining Celgene Corp position as of Q1 2017 after selling out during the quarter.
Silicon Valley Capital Partners sold 8,002 Celgene Corp shares in Q1 2017, an estimated $926K.
Silicon Valley Capital Partners first reported a position in Celgene Corp in Q1 2016 and held it in 4 quarters.
Silicon Valley Capital Partners's Celgene Corp position peaked at $1.25M in Q1 2016.
1,417 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2017.

Based on Silicon Valley Capital Partners's 13F filing for Q1 2017, filed 10 May 2017.